摘要
Abstract(#br)Developing selective strategies to treat metastatic cancers remains a significant challenge. Herein, we report the first antibody‐recruiting small molecule (ARM) that is capable of recognizing the urokinase‐type plasminogen activator receptor (uPAR), a uniquely overexpressed cancer cell...
-
单位yale university; 结构化学国家重点实验室; Yale School of Medicine